• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆纤维蛋白原在血管外科手术中的重要性。

The importance of plasma fibrinogen in vascular surgery.

作者信息

Postlethwaite J C

出版信息

Ann R Coll Surg Engl. 1976 Nov;58(6):457-64.

PMID:984690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2491878/
Abstract

The plasma fibrinogen concentration is directly related to blood viscosity, which in turn is inversely related to blood flow. The way in which the plasma fibrinogen level affects the clinical status of patients with peripheral vascular disease is discussed with reference to both retrospective and prospective studies of patients undergoing major arterial surgery. Animal experiments are described in which the effect of reducing the plasma fibrinogen level with oral clofibrate and parenteral Arvin (ancrod) on the patency of Dacron arterial grafts was studied.

摘要

血浆纤维蛋白原浓度与血液粘度直接相关,而血液粘度又与血流呈负相关。参照对接受主要动脉手术患者的回顾性和前瞻性研究,探讨了血浆纤维蛋白原水平影响外周血管疾病患者临床状况的方式。描述了动物实验,其中研究了口服氯贝丁酯和肠外给予安克洛酶(抗栓酶)降低血浆纤维蛋白原水平对涤纶动脉移植物通畅性的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce33/2491878/f1232ab14526/annrcse01479-0037-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce33/2491878/f1232ab14526/annrcse01479-0037-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce33/2491878/f1232ab14526/annrcse01479-0037-a.jpg

相似文献

1
The importance of plasma fibrinogen in vascular surgery.血浆纤维蛋白原在血管外科手术中的重要性。
Ann R Coll Surg Engl. 1976 Nov;58(6):457-64.
2
Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.安克洛酶治疗性去纤维蛋白原法:对外周血管疾病肢体血流的影响
Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):385-8.
3
Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
Angiology. 1979 Sep;30(9):594-9. doi: 10.1177/000331977903000903.
4
Haemorheological therapy.血液流变学疗法
Bibl Anat. 1977(16 Pt 2):481-3.
5
Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.使用氯贝丁酯治疗的间歇性跛行患者的踝部收缩压测量结果。
Ann Surg. 1975 Jun;181(6):799-802. doi: 10.1097/00000658-197506000-00006.
6
Effect of clofibrate on blood viscosity in intermittent claudication.氯贝丁酯对间歇性跛行患者血液粘度的影响。
Br Med J. 1974 Nov 2;4(5939):259-62. doi: 10.1136/bmj.4.5939.259.
7
Studies on haematocrit in peripheral arterial disease.外周动脉疾病中血细胞比容的研究。
Klin Wochenschr. 1986 Oct 1;64(19):969-74.
8
Effect of defibrinogenation on the early patency rate of experimental small calibre arterial grafts.去纤维蛋白原对实验性小口径动脉移植物早期通畅率的影响。
Br J Surg. 1987 Jun;74(6):508-10. doi: 10.1002/bjs.1800740630.
9
Treatment of severe intermittent claudication by controlled defibrination.通过可控去纤维蛋白法治疗严重间歇性跛行
Lancet. 1977 Mar 19;1(8012):625-6. doi: 10.1016/s0140-6736(77)92059-1.
10
[Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
Pol Tyg Lek. 1991;46(37-39):700-3.

本文引用的文献

1
Influence of blood viscosity on blood flow and the effect of low molecular weight dextran.血液粘度对血流的影响及低分子右旋糖酐的作用。
Br Med J. 1971 Dec 18;4(5789):716-9. doi: 10.1136/bmj.4.5789.716.
2
Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.使用氯贝丁酯的二级预防试验:关于纽卡斯尔和苏格兰试验的联合评论
Br Med J. 1971 Dec 25;4(5790):784-6. doi: 10.1136/bmj.4.5790.784.
3
An experimental and clinical evaluation of grafts in the venous system.静脉系统移植物的实验与临床评估
Surg Gynecol Obstet. 1970 Dec;131(6):1173-86.
4
Prognostic significance of rheological and biochemical findings in patients with intermittent claudication.间歇性跛行患者血流变学和生化检查结果的预后意义
Br Med J. 1973 Dec 8;4(5892):581-3. doi: 10.1136/bmj.4.5892.581.
5
The paradox in therapeutic defibrination.治疗性去纤维蛋白法中的矛盾现象。
Lancet. 1968 Mar 9;1(7541):485-6. doi: 10.1016/s0140-6736(68)91463-3.
6
Plasma-fibrinogen after replacement of heart valves by grafts and prostheses.心脏瓣膜移植和置换人工瓣膜后的血浆纤维蛋白原。
Lancet. 1971 Jan 2;1(7688):17-8. doi: 10.1016/s0140-6736(71)80007-7.
7
Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.使用氯贝丁酯治疗的间歇性跛行患者的踝部收缩压测量结果。
Ann Surg. 1975 Jun;181(6):799-802. doi: 10.1097/00000658-197506000-00006.